Barbara Teuchner

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

ABSTRACT Purpose New tumor therapies like immune checkpoint inhibitors and small molecule inhibitors of MEK and BRAF have increased the patient’s survival rate but can be burdened with severe side-effects including uveitis. Here, we show the spectrum, treatment, and outcome of uveitis types induced by tumor treatment. Methods In this retrospective study, we have included 54 patients from different centers who were developing uveitis under tumor therapy.

1. Bsteh, G, Hegen, H, Teuchner, B, et al. Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis. Mult Scler 2019: 25: 196–203. Google Scholar | SAGE Journals | ISI 2. Schippling, S, Balk, L, Costello, F, et al. Quality control for retinal OCT in multiple sclerosis: Validation of the OSCAR-IB criteria. Mult Scler 2014; 21(2): 163–170.